Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease.
作者信息
House A O, Abbott R J, Davidson D L, Ferguson I T, Lenman J A
出版信息
Br Med J. 1978 Dec 16;2(6153):1684. doi: 10.1136/bmj.2.6153.1684.
Abstract
摘要
相似文献
1
Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease.运动神经元病患者脑脊液和血液中铅浓度对青霉胺的反应。
Br Med J. 1978 Dec 16;2(6153):1684. doi: 10.1136/bmj.2.6153.1684.
2
Metabolism of low-dose paracetamol in patients with chronic neurological disease.慢性神经疾病患者体内低剂量对乙酰氨基酚的代谢
Xenobiotica. 1990 Jan;20(1):117-22. doi: 10.3109/00498259009046818.
3
Carbohydrate metabolism in motor neurone disease.运动神经元病中的碳水化合物代谢
J Neurol Neurosurg Psychiatry. 1977 Jun;40(6):533-7. doi: 10.1136/jnnp.40.6.533.
4
Management of patients with motor neurone disease.
Int Rehabil Med. 1980;2(3):111-5. doi: 10.3109/09638288009163970.
5
[Reports and prospects: neuromuscular diseases and manic-depressive psychoses].[报告与展望：神经肌肉疾病和躁狂抑郁症]
Arch Psicol Neurol Psichiatr. 1971 Nov-Dec;32(6):543-8.
6
Abnormal regulation of carbohydrate metabolism in motor neurone disease.运动神经元病中碳水化合物代谢的异常调节。
Diabetes Res. 1991 Feb;16(2):93-9.
7
D-penicillamine and N-acetyl-D-penicillamine in lead poisoning.D-青霉胺和N-乙酰-D-青霉胺用于铅中毒治疗
Postgrad Med J. 1974 Aug;50 Suppl 2:14-16.
8
Lead and motor neurone disease.铅与运动神经元病。
Br Med J. 1978 Jul 29;2(6133):308.
9
Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases.多发性硬化症和退行性疾病中的血浆及脑脊液色氨酸
J Neurol Neurosurg Psychiatry. 1979 Jul;42(7):640-1. doi: 10.1136/jnnp.42.7.640.
10
Diagnostic and therapeutic uses of D-penicillamine in lead poisoning.D-青霉胺在铅中毒中的诊断和治疗用途。
Postgrad Med J. 1974 Aug;50 Suppl 2:17-20.
引用本文的文献
1
Understanding the human health effects of chemical mixtures.了解化学混合物对人类健康的影响。
Environ Health Perspect. 2002 Feb;110 Suppl 1(Suppl 1):25-42. doi: 10.1289/ehp.02110s125.
2
High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid.血清和脑脊液中铅的高精度（稳定同位素稀释）测量。
Br J Ind Med. 1984 Aug;41(3):313-9. doi: 10.1136/oem.41.3.313.
3
Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.肌萎缩侧索硬化症及其他神经疾病患者脑脊液和血清铅水平的测定
Experientia. 1989 Dec 1;45(11-12):1108-10. doi: 10.1007/BF01950171.
本文引用的文献
1
Motor neurone disease and exposure to lead.运动神经元病与铅暴露
J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):877-85. doi: 10.1136/jnnp.33.6.877.
2
Amyotrophic lateral sclerosis and metallic toxins.肌萎缩侧索硬化症与金属毒素
Arch Environ Health. 1968 Nov;17(5):712-9. doi: 10.1080/00039896.1968.10665310.
3
Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中铅的异常组织分布。
J Neurol Sci. 1976 Oct;29(2-4):259-65. doi: 10.1016/0022-510x(76)90175-1.
4
Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.与对照组相比，采用无火焰原子吸收分光光度法测定的肌萎缩侧索硬化症患者血浆铅水平升高。
J Neurol Neurosurg Psychiatry. 1978 May;41(5):389-93. doi: 10.1136/jnnp.41.5.389.
5
Improvement of spinal amyotrophy by penicillamine therapy.青霉胺疗法对脊髓性肌萎缩症的改善作用。
Lancet. 1977 Nov 12;2(8046):1034-5.
Zotero 插件